UBS Initiates Coverage On Shattuck Labs with Buy Rating, Announces Price Target of $17

10/12/2026
Impact: 80
Healthcare

UBS analyst Alice Nettleton has initiated coverage on Shattuck Labs (NASDAQ: STTK) with a Buy rating. The firm has set a price target of $17 for the company's stock.

AI summary, not financial advice

Share: